Cargando…

Deep remission from induction chemotherapy predicts favorable long-term survivals in early stage extranodal nasal NK/T-cell lymphoma receiving sequential chemotherapy and radiation

Objective: We aimed to assess the association between induction chemotherapy (CT) response and survivals and to explore an induction CT response-adapted treatment strategy for localized extranodal NK/T-cell lymphoma (NKTCL) receiving first-line sequential CT and radiation (RT). Methods: We retrospec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qi, Fei, Zhou, Wenyuan, Xie, Yan, Sun, Yan, Wu, Meng, Chai, Yue, Chen, Bo, Lin, Ningjing, Liu, Weiping, Ding, Ning, Li, Yexiong, Dong, Mei, Song, Yuqin, Zhu, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699755/ https://www.ncbi.nlm.nih.gov/pubmed/36326691 http://dx.doi.org/10.18632/aging.204355

Ejemplares similares

A prospective phase II study of L-asparaginase- CHOP plus radiation in newly diagnosed extranodal NK/T-cell lymphoma, nasal type
por: Lin, Ningjing, et al.
Publicado: (2013)

Complete remission after first-line radio-chemotherapy as predictor of survival in extranodal NK/T cell lymphoma
por: Chauchet, Adrien, et al.
Publicado: (2012)

Radiation dose reduction for patients with extranodal NK/T-cell lymphoma with complete response after initial induction chemotherapy
por: Wang, Liang, et al.
Publicado: (2016)

Mosquito Bite-Induced Localized NK/T-Cell Lymphoma Relapsed in a Patient with Complete Remission of Extranodal NK/T-Cell Lymphoma, Nasal Type
por: Kondo, Makoto, et al.
Publicado: (2019)

Treatment outcomes of and prognostic factors for definitive radiotherapy with and without chemotherapy for Stage I/II nasal extranodal NK/T-cell lymphoma
por: Yang, Claire Wen-Chi, et al.
Publicado: (2017)

Multifocal primary cutaneous extranodal NK/T lymphoma nasal type
por: de Vasconcelos, Pedro, et al.
Publicado: (2016)

Educational Case: Extranodal NK/T-Cell Lymphoma, Nasal Type
por: Jia, Yue, et al.
Publicado: (2019)

Concurrent IMRT and weekly cisplatin followed by GDP chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell lymphoma
por: Ke, Q-H, et al.
Publicado: (2014)

Evaluation of different staging systems and prognostic analysis of nasal-type extranodal NK/T-cell lymphoma based on consistent LVDP chemotherapy regimen
por: Wu, Wanchun, et al.
Publicado: (2022)

Comparison of the clinical efficacies of two L‐asparaginase‐based chemotherapy regimens for newly diagnosed nasal‐type extranodal NK/T‐cell lymphoma
por: Wu, Wanchun, et al.
Publicado: (2023)

Characteristics and Clinical Implications of the Nasal Microbiota in Extranodal NK/T-Cell Lymphoma, Nasal Type
por: Shi, Zhuangzhuang, et al.
Publicado: (2021)

PEG-L-CHOP treatment is safe and effective in adult extranodal NK/T-cell lymphoma with a low rate of clinical hypersensitivity
por: Zheng, Wen, et al.
Publicado: (2018)

Extranodal nasal-type NK/T-cell lymphoma of the palate and paranasal sinuses
por: Nikolaos, Nikitakis, et al.
Publicado: (2012)

Nasal-type extranodal T-cell/NK lymphoma in association with hemophagocytic syndrome
por: Guedes, Juliana Chaves Ruiz, et al.
Publicado: (2018)

Extranodal NK/T-cell lymphoma, nasal type with extensive cardiopulmonary involvement
por: Marques-Piubelli, Mario L., et al.
Publicado: (2021)

Clinical and otorhinolaryngological aspects of extranodal NK/T cell lymphoma, nasal type()()
por: Miyake, Marcel Menon, et al.
Publicado: (2014)

VAD chemotherapy as remission induction for multiple myeloma.
por: Anderson, H., et al.
Publicado: (1995)

Sustained remission of multi-line relapsed extranodal NK/T-cell lymphoma, nasal type, following sintilimab and chidamide: A case report
por: Xu, Jingyan, et al.
Publicado: (2021)

Extranodal NK/T cell lymphoma, nasal type: a rare diagnosis with common nasal presentation
por: Mohd Ramli, Siti Sarah, et al.
Publicado: (2021)

Extranodal NK-T-Cell Lymphoma, Nasal-Type Misdiagnosed as Erythema Multiforme with Nasal Fungal Infection
por: Jeong, Soo Hyun, et al.
Publicado: (2022)

Sequential chemotherapy followed by radiotherapy versus concurrent chemoradiotherapy in patients with stage I/II extranodal natural killer/T-cell lymphoma, nasal type
por: Lee, Jieun, et al.
Publicado: (2013)

A systematic comparison of treatment modalities for nasal extranodal natural killer/T-cell lymphoma in early stages between concurrent chemoradiotherapy and sequential chemotherapy
por: Qian, Ming, et al.
Publicado: (2017)

Extranodal NK/T-Cell Lymphoma, Nasal Type, Presenting as a Breast Mass
por: Rahal, Ahmad, et al.
Publicado: (2015)

Granulysin, a novel marker for extranodal NK/T cell lymphoma, nasal type
por: Lo Bello, Giuseppe, et al.
Publicado: (2018)

Extranodal NK/T-cell lymphoma, nasal type without evidence of EBV infection
por: Wang, Wei, et al.
Publicado: (2020)

Complete remission in CD30-positive refractory extranodal NK/T-cell lymphoma with brentuximab vedotin
por: Kim, Hee Kyung, et al.
Publicado: (2015)

Systemic release of osteoprotegerin during oxaliplatin-containing induction chemotherapy and favorable systemic outcome of sequential radiotherapy in rectal cancer
por: Meltzer, Sebastian, et al.
Publicado: (2016)

Extranodal NK/T cell lymphoma
por: Jeong, Seong Hyun
Publicado: (2020)

Extranodal T- and NK-cell lymphomas
por: de Leval, Laurence, et al.
Publicado: (2022)

Treatment of localized extranodal NK/T cell lymphoma, nasal type: a systematic review
por: Kim, Seok Jin, et al.
Publicado: (2018)

Characteristics of Extranodal NK/T-Cell Lymphoma, Nasal Type, Compared with Nasal Diffuse Large B-cell Lymphoma
por: Tanaka, Hirotaka, et al.
Publicado: (2023)

Extended Course and Increased Dose of Initial Chemotherapy for Extranodal Nasal Type Natural Killer/T (NK/T)-Cell Lymphoma in Patients <60 Years Old: A Single-Center Retrospective Cohort Study
por: Xu, Yan, et al.
Publicado: (2016)

An autopsy case of primary extranodal NK/T cell lymphoma (extranodal NK/T-cell lymphoma) of the bile duct
por: Ito, Hiroyuki, et al.
Publicado: (2019)

Phase II trial of concurrent chemoradiotherapy with L-asparaginase and MIDLE chemotherapy for newly diagnosed stage I/II extranodal NK/T-cell lymphoma, nasal type (CISL-1008)
por: Yoon, Dok Hyun, et al.
Publicado: (2016)

Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making
por: Chen, Si-Ye, et al.
Publicado: (2020)

Feasibility of low-dose radiotherapy for patients with stage I/II extranodal NK-/T-cell lymphoma, nasal type achieving complete response after l-asparaginase-containing chemotherapy
por: Kim, Jae Sik, et al.
Publicado: (2022)

Primary extranodal NK/T cell lymphoma, nasal-type of uterus with adenomyosis: a case report
por: Fang, Jian-chen, et al.
Publicado: (2014)

CD56-Negative Extranodal NK/T-Cell Lymphoma, Nasal Type, with Extranasal Cutaneous Involvement
por: Kim, Hee Joo, et al.
Publicado: (2015)

Extranodal NK/T-cell Lymphoma, Nasal Type Accompanied by PR3-ANCA-associated Glomerulonephritis
por: Tamoto, Yuta, et al.
Publicado: (2017)

Late diagnosis: a case of rapidly progressive extranodal NK/T cell lymphoma, nasal type
por: Mori, Hiroyuki, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_imcrr76nc75tc7d03vp6felfee